A Q4 2019 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.4B+5.6% YoY

Gross Profit

$737M53.9% margin

Operating Income

$250M18.3% margin

Net Income

$194M14.2% margin

EPS (Diluted)

$0.62

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

$314M

Free Cash Flow

$284M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$9.5B

Total Liabilities

$4.7B

Stockholders' Equity

$4.7B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.3B	+5.6%
Gross Profit	$737M	$709M	+3.9%
Operating Income	$250M	$244M	+2.5%
Net Income	$194M	$195M	-0.5%

Revenue Segments

Life Sciences and Applied Markets

$622M46%

Agilent CrossLab

$476M35%

Diagnostics and Genomics

$269M20%

Geographic Segments

Americas

$530M39%

Asia Pacific

$472M35%

Europe

$365M27%